StreetInsider.com News Articles

Form 4 Doximity, Inc. For: Jul 15 Filed by: Sitaram Siddharth

Mon, 20 Jul 2026 10:15:00 -0400

si-local-file:///var/storage/secattach/20260720/26788234.html

Form 4 Doximity, Inc. For: Jul 15 Filed by: Sitaram Siddharth

Mon, 20 Jul 2026 10:15:00 -0400

si-local-file:///var/storage/secattach/20260720/26788234.html

OpenEvidence reaches $300m revenue run rate, Bank of America says

Mon, 20 Jul 2026 08:57:15 -0400

Investing.com -- OpenEvidence is generating close to $300m in annualized revenue, double its revenue run rate from about seven months ago, according to The Information and cited on Bloomberg, Bank of America said in a note on Monday.

The company was considering a $200m capital raise after receiving offers from investors at a valuation of around $20bn, but is unlikely to proceed given concerns around diluting founders and shareholders, the bank added.

OpenEvidence exited 2025 at a roughly $150m annualized revenue run rate. The pharma advertising market is approximately $3bn and growing 5% to 7% per year, Bank of America noted.

Some of

OpenEvidence reaches $300m revenue run rate, Bank of America says

Mon, 20 Jul 2026 08:57:15 -0400

OpenEvidence exited 2025 at a roughly $150m annualized revenue run rate. The pharma advertising market is approximately $3bn and growing 5% to 7% per year, Bank of America noted.

Some of

Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026

Thu, 16 Jul 2026 16:01:00 -0400

SAN FRANCISCO--(BUSINESS WIRE)-- Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2026 after market close on August 6, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.

To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call.

About Doximity

Founded in 2010, Doximity is the

Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026

Thu, 16 Jul 2026 16:01:00 -0400

About Doximity

Founded in 2010, Doximity is the

Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026

Thu, 16 Jul 2026 16:01:00 -0400

About Doximity

Founded in 2010, Doximity is the

Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026

Thu, 16 Jul 2026 16:01:00 -0400

About Doximity

Founded in 2010, Doximity is the

Form 144 Doximity, Inc. Filed by: Sitaram Siddharth

Wed, 15 Jul 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260715/26774215.html

Form 144 Doximity, Inc. Filed by: Sitaram Siddharth

Wed, 15 Jul 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260715/26774215.html

Doximity Outranks OpenEvidence, Frontier Models in Independent Stanford-Harvard Study of Clinical AI Safety

Wed, 15 Jul 2026 14:26:00 -0400

Doximity Ask outranked OpenEvidence, GPT-5.6 Sol, Claude Fable 5, and other frontier models

SAN FRANCISCO--(BUSINESS WIRE)-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Doximity Ask, its HIPAA-compliant clinical AI platform, outperformed leading frontier AI models in the NOHARM (Numerous Options Harm Assessment for Risk in Medicine) benchmark, one of the most comprehensive independent evaluations of clinical AI safety to date.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715030379/en/

Doximity Outranks OpenEvidence, Frontier Models in
</article>
<article>
<h1>Doximity Outranks OpenEvidence, Frontier Models in Independent Stanford-Harvard Study of Clinical AI Safety</h1>
<p>Wed, 15 Jul 2026 14:26:00 -0400</p>
<p class=

Doximity Ask outranked OpenEvidence, GPT-5.6 Sol, Claude Fable 5, and other frontier models

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715030379/en/

Doximity Ask outranked OpenEvidence, GPT-5.6 Sol, Claude Fable 5, and other frontier models

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715030379/en/

Doximity Ask outranked OpenEvidence, GPT-5.6 Sol, Claude Fable 5, and other frontier models

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715030379/en/